Navigation Links
Genstruct's Andrea Matthews Selected for Mass High Tech's 'People to Watch Under 30'
Date:10/9/2007

CAMBRIDGE, Mass., Oct. 9 /PRNewswire/ -- Genstruct Inc., a biotechnology company translating the complexity of human biology to develop new successful therapeutics, today announced that Andrea Matthews (age 25), manager of its Scientific Programs, was selected by Mass High Tech for its "People to Watch Under 30."

"We are proud to have a young, successful individual like Andrea as part of our team," said Dr. Keith O. Elliston, president and CEO at Genstruct. "She has been a go-getter ever since she started at Genstruct during college. With her strong business, technology and scientific acumen, Andrea serves as a valued translator between our scientific and development teams. She not only shows significant initiative in advancing her career, but also excels in her personal life by volunteering to help Cambridge-area youth and competing in triathlons."

Ms. Matthews received her B.A. cum laude in biochemistry and molecular biology from Boston University in 2004. As an undergraduate summer student, she began working at Genstruct as the first full-time female employee for the company and the youngest by more than 10 years.

In her role as the manager of Scientific Programs at Genstruct, Ms. Matthews drives the progress of scientific and technology development for the company by prioritizing and managing requests across all of its pharmaceutical research projects. During her four years at Genstruct, she has presented scientific information and successfully gone head-to-head with scientists with more than 20 years of experience.

About Genstruct

Founded in 2002, Genstruct is a biotechnology company focused on elucidating the complexity of biology for the development of successful therapeutics. By modeling the components within the whole biological system, Genstruct delivers a deep molecular understanding of diseases and drug action, as well as mechanistic biomarkers to accelerate drug discovery and development programs. Genstruct engages in internal discovery and external development partnerships with top tier pharmaceutical companies, which apply systems biology in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. The privately held company is based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assembly, and Epistemics Engine are trademarks of Genstruct, Inc. All other trademarks or registered trademarks are properties of their respective owners.

Contact:

Karen Higgins

A & E Communications for Genstruct

(610) 831-5723

khiggins@aandecomm.com


'/>"/>
SOURCE Genstruct Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. San Diego firm selected for Madison Wi-Fi project
2. Milwaukee-based eFilm software selected by InSight Health, announces Workstation upgrade
3. Berbee Selected by Microsoft as Featured Speaker for New Product Launch
4. Can sales outsourcing grow Wisconsin biotechs?
5. Wisconsin biotechs plan Japan trade mission
6. Madison biotechs get Commerce grants
7. Midwest shares in stock-market bloodshed as biotechs falter
8. Technology helps but the best way to reduce Sarbox cost is with people
9. Age of empowered individuals: People power behind robust computing
10. Two-week notices: People are still concerned
11. Power for the people
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
Breaking Biology Technology:
(Date:7/20/2017)... 20, 2017 Delta (NYSE: DAL ) customers now ... aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at ... Delta,s biometric boarding pass experience ... is now integrated into the boarding process to allow eligible Delta SkyMiles ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
Breaking Biology News(10 mins):